Failure Of Roche’s Nine-Year Alzheimer’s Prevention Study Disappointing, But No Surprise
Crenezumab Fails Again
The nine year study was carried out in the Antioquia region of Colombia, where a genetic mutation makes some people almost certain to develop Alzheimer’s disease.. • Source: Shutterstock
